CHARLES CAPACI: Open Payments
NPI 1457665580 · LANSDALE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,154 in 120 payments from 17 companies in 2025. Trend: 2023 $1,819 · 2024 $1,798 · 2025 $2,154
Food & beverage: $2,154
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 30 | $527 |
| ABBVIE INC. | 33 | $457 |
| Galderma Laboratories, L.P. | 14 | $244 |
| GENZYME CORPORATION | 8 | $179 |
| Organon LLC | 10 | $127 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $119 |
| Regeneron Healthcare Solutions, Inc. | 3 | $80 |
| Incyte Corporation | 3 | $77 |
| UCB, Inc. | 3 | $76 |
| Botanix SB Inc | 2 | $55 |
Products named: TREMFYA, RINVOQ, DUPIXENT, NEMLUVIO, SKYRIZI, OPZELURA, Bimzelx, ILUMYA.
Industry payments across PA — which companies pay providers there.
